[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO984189L - FremgangsmÕte for behandling av bipolar forstyrrelse - Google Patents

FremgangsmÕte for behandling av bipolar forstyrrelse

Info

Publication number
NO984189L
NO984189L NO984189A NO984189A NO984189L NO 984189 L NO984189 L NO 984189L NO 984189 A NO984189 A NO 984189A NO 984189 A NO984189 A NO 984189A NO 984189 L NO984189 L NO 984189L
Authority
NO
Norway
Prior art keywords
bipolar disorder
procedure
treatment
provides
present
Prior art date
Application number
NO984189A
Other languages
English (en)
Other versions
NO984189D0 (no
Inventor
Jr Charles M Beasley
Gary D Tollefson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984189L publication Critical patent/NO984189L/no
Publication of NO984189D0 publication Critical patent/NO984189D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)

Abstract

Foreliggende oppfinnelse fremskaffer en fremgangsmåte for behandling av bipolar for- styrrelse, omfattende administrering av en effektiv mengde olanzapin til en pasient som trenger dette. I tillegg fremskaffer foreliggende oppfinnelse en fremgangsmåte for be- handling av bipolar forstyrrelse, stor depressiv episode.
NO984189A 1996-03-11 1998-09-11 Fremgangsmåte for behandling av bipolar forstyrrelse NO984189D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1315996P 1996-03-11 1996-03-11
PCT/US1996/019575 WO1997033577A1 (en) 1996-03-11 1996-12-04 Method for treating bipolar disorder

Publications (2)

Publication Number Publication Date
NO984189L true NO984189L (no) 1998-09-11
NO984189D0 NO984189D0 (no) 1998-09-11

Family

ID=21758606

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984189A NO984189D0 (no) 1996-03-11 1998-09-11 Fremgangsmåte for behandling av bipolar forstyrrelse

Country Status (15)

Country Link
EP (1) EP0889725A4 (no)
JP (1) JP2000506859A (no)
KR (1) KR19990087713A (no)
CN (1) CN1213966A (no)
AU (1) AU734011B2 (no)
BR (1) BR9612548A (no)
CZ (1) CZ290298A3 (no)
EA (1) EA000758B1 (no)
HU (1) HUP9903679A3 (no)
IL (1) IL126162A0 (no)
NO (1) NO984189D0 (no)
NZ (1) NZ326031A (no)
PL (1) PL328925A1 (no)
TR (1) TR199801797T2 (no)
WO (1) WO1997033577A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL139592A (en) * 1998-05-22 2005-08-31 Lilly Co Eli Pharmaceutical composition containing an atypical antipsychotic and a serotonin reuptake inhibitor for combination therapy of refractory depression
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
JP2002516864A (ja) * 1998-05-29 2002-06-11 イーライ・リリー・アンド・カンパニー 両極性疾患の処置のための組合せ治療
ES2211205T3 (es) * 1998-11-23 2004-07-01 Sepracor Inc. Composiciones farmaceuticas que contienen olanzapina-n-oxido.
JP2002530339A (ja) 1998-11-23 2002-09-17 セプラコール， インク． ２−ヒドロキシメチルオランザピン組成物及び方法
JP2002530341A (ja) * 1998-11-23 2002-09-17 セプラコール， インク． デスメチルオランザピン組成物及び方法
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Also Published As

Publication number Publication date
JP2000506859A (ja) 2000-06-06
EP0889725A4 (en) 2000-01-19
CZ290298A3 (cs) 1999-10-13
AU734011B2 (en) 2001-05-31
AU1330797A (en) 1997-10-01
CN1213966A (zh) 1999-04-14
WO1997033577A1 (en) 1997-09-18
PL328925A1 (en) 1999-03-01
TR199801797T2 (xx) 1998-12-21
EA199800819A1 (ru) 1999-02-25
NZ326031A (en) 2001-05-25
HUP9903679A3 (en) 2001-10-29
BR9612548A (pt) 1999-07-20
KR19990087713A (ko) 1999-12-27
NO984189D0 (no) 1998-09-11
EA000758B1 (ru) 2000-04-24
IL126162A0 (en) 1999-05-09
HUP9903679A2 (hu) 2000-04-28
EP0889725A1 (en) 1999-01-13

Similar Documents

Publication Publication Date Title
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DK0723444T3 (da) Levobupivacain, som er egnet til behandling af kronisk smerte
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
IS5591A (is) Grunnmassaprótínsamsetningar til sáragræðslu
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
DE69814394D1 (de) Verwendung von levobupivacain
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
DE69813200D1 (de) Verbesserung der wundheilung mit cm101/gbs-toxin
NO984446L (no) FremgangsmÕte for behandling av smerte
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
DE69924979D1 (de) Behandlung von chronischen schmerzen
EA199800535A1 (ru) Способ лечения боли
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
NO984190L (no) FremgangsmÕte for behandling av insomnia
NO990436L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
NO984198L (no) FremgangsmÕte for behandling av aggresjon
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
ATE72115T1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-
NO20024545L (no) Fremgangsmåte for behandling av kongestiv hjertefeil
NO985325L (no) Anvendelse av substituert azaspiran ved behandling av astma
UA8280A (uk) Спосіб лікування псоріазу
UA7180C2 (uk) Препарат для лікування та профілактики атерогенних дисліпопротеїнемій та синдрому гіперкоагуляції

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application